Wade L, Neudorff L, et al
Native amylin readily forms amyloid fibrils protein aggregates that not only render the peptide non-functional but are also implicated in the pancreatic pathology of type 2 diabetes
In fact, clinical weight loss trials with tirzepatide monotherapy show 2022% body weight reduction over 68 weeksresults that rival or exceed most multi-agent protocols reported in the literature
Preclinical (animal) data Rodent studies suggest BPC-157 may: Promote blood vessel growth Enhance tendon fibroblast activity Reduce inflammation Protect gastrointestinal tissues However, these findings: Use doses far above any human equivalent Use controlled laboratory injuries Do not predict human efficacy 2
In lean C57BL/6J mice, chronic treatment with hGH led to a significant increase in body weight, becoming apparent by day 8
Cloudiness suggests precipitation, aggregation, or contamination